Get started
Cochlear LimitedCochlear LimitedCochlear Limited

Cochlear Limited

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.41 B‬ AUD
Dividend yield (indicated)
3.27%
Price to earnings Ratio (TTM)
34.02
Basic EPS (TTM)
5.28 AUD
Net income (FY)
‪388.90 M‬ AUD
Revenue (FY)
‪2.36 B‬ AUD
Shares float
‪61.06 M‬
Beta (1Y)
0.80

Employees


Employees (FY)
‪5.5 K‬
Change (1Y)
+500 +10.00%
Revenue / Employee (1Y)
‪428.33 K‬ AUD
Net income / Employee (1Y)
‪70.71 K‬ AUD

About Cochlear Limited


Sector
Health Technology
Industry
Medical Specialties
CEO
Diggory William Howitt
Website
cochlear.com
Headquarters
Sydney
Founded
1983
IPO date
Dec 4, 1995
Identifiers
2
ISIN AU000000COH5
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following geographical segments: Americas, EMEA, Asia Pacific, Corporate and Other. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Check out other big names from the same industry as COH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VAS
Vanguard Australian Shares Index ETF
Weight 0.63%
Market value ‪213.85 M‬
VXUS
Vanguard Total International Stock ETF
Weight 0.03%
Market value ‪177.81 M‬
VEA
Vanguard FTSE Developed Markets ETF
Weight 0.04%
Market value ‪115.62 M‬
IEFA
iShares Core MSCI EAFE ETF
Weight 0.03%
Market value ‪58.07 M‬
A200
BetaShares Australia 200 ETF
Weight 0.45%
Market value ‪30.91 M‬
EFA
iShares MSCI EAFE ETF
Weight 0.04%
Market value ‪27.23 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight 0.03%
Market value ‪27.00 M‬
IOZ
iShares Core S&P/ASX 200 ETF
Weight 0.43%
Market value ‪25.50 M‬
BBAX
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
Weight 0.37%
Market value ‪22.66 M‬
FAIR
BetaShares Australian Sustainability Leaders ETF
Weight 2.61%
Market value ‪21.29 M‬
MVW
VanEck Australian Equal Weight ETF
Weight 0.91%
Market value ‪20.40 M‬

Explore more ETFs 

Frequently asked questions


The current price of COH is 174.42 AUD — it has decreased by −2.65% in the past 24 hours. Watch Cochlear Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Cochlear Limited stocks are traded under the ticker COH.
COH stock has fallen by −4.73% compared to the previous week, the month change is a −32.07% fall, over the last year Cochlear Limited has showed a −33.60% decrease.
We've gathered analysts' opinions on Cochlear Limited future price: according to them, COH price has a max estimate of 304.00 AUD and a min estimate of 194.00 AUD. Watch COH chart and read a more detailed Cochlear Limited stock forecast: see what analysts think of Cochlear Limited and suggest that you do with its stocks.
COH reached its all-time high on Jul 26, 2024 with the price of 350.31 AUD, and its all-time low was 2.68 AUD and was reached on Dec 4, 1995. View more price dynamics on COH chart.
See other stocks reaching their highest and lowest prices.
COH stock is 4.16% volatile and has beta coefficient of 0.80. Track Cochlear Limited stock price on the chart and check out the list of the most volatile stocks — is Cochlear Limited there?
Today Cochlear Limited has the market capitalization of ‪11.39 B‬, it has decreased by −6.46% over the last week.
Yes, you can track Cochlear Limited financials in yearly and quarterly reports right on TradingView.
Cochlear Limited is going to release the next earnings report on Aug 13, 2026. Keep track of upcoming events with our Earnings Calendar.
COH earnings for the last half-year are 2.98 AUD per share, whereas the estimation was 3.15 AUD, resulting in a −5.41% surprise. The estimated earnings for the next half-year are 3.34 AUD per share. See more details about Cochlear Limited earnings.
Cochlear Limited revenue for the last half-year amounts to ‪1.18 B‬ AUD, despite the estimated figure of ‪1.22 B‬ AUD. In the next half-year revenue is expected to reach ‪1.28 B‬ AUD.
COH net income for the last half-year is ‪161.50 M‬ AUD, while the previous report showed ‪183.80 M‬ AUD of net income which accounts for 0.00% change. Track more Cochlear Limited financial stats to get the full picture.
Cochlear Limited dividend yield was 1.43% in 2025, and payout ratio reached 72.35%. The year before the numbers were 1.23% and 75.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 14, 2026, the company has ‪5.5 K‬ employees. See our rating of the largest employees — is Cochlear Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cochlear Limited EBITDA is ‪570.20 M‬ AUD, and current EBITDA margin is 25.45%. See more stats in Cochlear Limited financial statements.
Like other stocks, COH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cochlear Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cochlear Limited technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cochlear Limited stock shows the sell signal. See more of Cochlear Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.